Global Statistics Representing Capnography Device Market Scenario
Capnography device is used for patient safety during anesthesia and sedation. It helps in diagnosing the cause of the respiratory ailment. The use of capnography is very critical during Cardiopulmonary Resuscitation (CPR) as it delivers breath-to-breath ventilation data with real-time feedback. It is utilized for monitoring the concentration or partial pressure of exhaled carbon dioxide. Capnography is a sophisticated device necessitating skilled professionals to operate. The increasing need for capnography device in prolonged illnesses and protracted treatments associated with lung diseases is expected to tap ample opportunities in the market. According to the study of Cancer Research U.K., the increasing death toll due to cancer globally has compelled the clinical perseverance to embrace advanced alternatives, such as capnography device. According to the American Cancer Society, in 2018, almost 1.7 million new cancer cases were registered in the U.S., and nearly 0.6 million individuals died.
Factors affecting the capnography device market in the future are the increasing number of surgeries, substantial development in portable or point-of-care devices, and clinical aids of capnography device over pulse oximetry.
Against the backdrop of favorable conditions and remarkable drivers, the capnography device market is expected to reach a value of U.S.D 298.1 million by 2026, with a CAGR of 11.2%, driven by the adoption of mainstream capnography technology.
To understand the capnography device market in an all-inclusive manner, we have considered the product, technology, application, and end-user as the key segmentation criteria.
The hand-held product segment, among other product segments, is expected to hold the largest share in the market within the forecast period. This device is small, and light in weight used for measuring the carbon dioxide in respiratory gases in adults, pediatrics, and infant patients. Multi-parameter is one of the products, which can evaluate two or more parameters simultaneously.
The mainstream segment, among other technology segments, spearheads in the market, owing to its advantages such as higher precision, faster response time, and better suitability for infants and children. Both mainstream and sidestream technology provides numerous benefits for the healthcare sector, but mainstream technology comes with further merit such as no pollution of operating room environment, no obstruction, and eliminates the need for gas sampling and scavenging as the measurement is done at the airway.
The trauma and emergency care segment, among other application segments, is expected to witness substantial growth. Consumer awareness regarding clinical benefits offered by advanced devices for the management of trauma cases is increasing thereby propelling the trauma and emergency care segment in the market. Capnography device is used in emergency cases in healthcare centers to measure and correctly adjust the ventilation parameters within a short period.
The hospital segment, among other end-use segments, is gaining significant traction in the market due to its ability to calculate ventilator measurement of intubated patients, minimally invasive nature, and ease-of-use. Waveform capnography is one of the latest and most innovative measurement methodologies in the field of hospital equipment. It analyzes the amount of CO2 in exhaled breath of the patient and provides quick and accurate ways to assess the status in a wide variety of conditions.
To evaluate the global capnography device market more comprehensively, we have explored the market across five regions, namely North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
The North America capnography device market is expected to hold major share in the market during the forecast period, owing to the rising prevalence of respiratory diseases as a consequence of unhealthy lifestyles and high-stress levels. Hence, the respiratory disease is endemic in the region, resulting in an increasing death toll. To address this issue, the deliberate demand for smaller capnography devices has subsequently increased in North America. The Lubbock hospital in Texas recently launched a new waveform technology capnography, which has numerous benefits compared to traditional devices.
The of Asia-Pacific in the global capnography device market can be attributed to the increasing awareness and rising incidents of preterm birth. Moreover, several government initiatives regarding health safety are also expected to provide an impetus to the regional market growth. Moreover, improving healthcare systems, rising healthcare spending, and increasing awareness levels pertaining to the adoption of capnography technology are few other regional market drivers.
The LAMEA capnography device market is expected to witness steady growth during the forecast period. This is attributed to the vogue of plastic surgery and the prevalence of respiratory ailments. Latin America comprises of several emerging nations, where nearly 600 million inhabitants exhibit a demographic transition that combines significant population growth with a phenomenon of progressive geriatric population. The region has a vast majority of patients suffering from asthma receiving inadequate care in terms of diagnosis and monitoring, resulting in a substantial rate of morbidity.
The market is competitive in nature, and a smaller number of capnography device market participants have a high level of dominance. Most notable market participants are Nihon Kohden (Japan), Philips (Netherlands), Medtronic (Ireland), Smiths Group (U.K.), Masimo Corporation (U.S.), Drägerwerk AG & Co. KGaA (Germany), Hill-Rom Holdings (U.S.), Nonin Medical (U.S.), Infinium Medical (U.S.), Criticare Technologies (U.S.), SCHILLER (Switzerland), Zoe Medical (U.S.), Edan Instruments (China), and Burtons Medical Equipment (U.K.). These market participants are incorporating various strategies such as collaborations, product launch, geographical expansions, and acquisitions, to capture more significant market share. For instance, Covidien plc acquired Oridion Systems Ltd, a capnography respiratory monitors and modules manufacturer, for worth USD 346 million.
What Details Does the Capnography Device Market Report Cover?
Capnography Device Market Segmentation